IBDEI0VJ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15595,0)
 ;;=473.8^^95^950^21
 ;;^UTILITY(U,$J,358.3,15595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15595,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,15595,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,15595,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,15596,0)
 ;;=463.^^95^950^22
 ;;^UTILITY(U,$J,358.3,15596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15596,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,15596,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,15596,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,15597,0)
 ;;=011.90^^95^950^23
 ;;^UTILITY(U,$J,358.3,15597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15597,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,15597,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,15597,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,15598,0)
 ;;=465.9^^95^950^24
 ;;^UTILITY(U,$J,358.3,15598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15598,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,15598,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,15598,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,15599,0)
 ;;=599.0^^95^950^25
 ;;^UTILITY(U,$J,358.3,15599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15599,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,15599,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,15599,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,15600,0)
 ;;=616.10^^95^950^26
 ;;^UTILITY(U,$J,358.3,15600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15600,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,15600,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,15600,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,15601,0)
 ;;=277.30^^95^951^1
 ;;^UTILITY(U,$J,358.3,15601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15601,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,15601,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,15601,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,15602,0)
 ;;=277.31^^95^951^3
 ;;^UTILITY(U,$J,358.3,15602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15602,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,15602,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,15602,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,15603,0)
 ;;=277.39^^95^951^2
 ;;^UTILITY(U,$J,358.3,15603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15603,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,15603,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,15603,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,15604,0)
 ;;=446.21^^95^951^4
 ;;^UTILITY(U,$J,358.3,15604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15604,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,15604,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,15604,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,15605,0)
 ;;=580.0^^95^951^8
 ;;^UTILITY(U,$J,358.3,15605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15605,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,15605,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,15605,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,15606,0)
 ;;=580.4^^95^951^9
 ;;^UTILITY(U,$J,358.3,15606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15606,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,15606,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,15606,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,15607,0)
 ;;=580.9^^95^951^7
 ;;^UTILITY(U,$J,358.3,15607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15607,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,15607,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,15607,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,15608,0)
 ;;=582.0^^95^951^14
 ;;^UTILITY(U,$J,358.3,15608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15608,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,15608,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,15608,2)
 ;;=^270347
